相似文献
1
Precision Medicine and Obesity.精准医学与肥胖
Gastroenterol Clin North Am. 2021 Mar;50(1):127-139. doi: 10.1016/j.gtc.2020.10.005. Epub 2021 Jan 5.
2
Nutrigenetics/Nutrigenomics, Personalized Nutrition, and Precision Healthcare.营养遗传学/营养基因组学、个性化营养和精准医疗。
Curr Nutr Rep. 2020 Dec;9(4):338-345. doi: 10.1007/s13668-020-00327-z.
3
Guide and Position of the International Society of Nutrigenetics/Nutrigenomics on Personalised Nutrition: Part 1 - Fields of Precision Nutrition.国际营养基因学/营养基因组学学会关于个性化营养的指南与立场：第1部分 - 精准营养领域
J Nutrigenet Nutrigenomics. 2016;9(1):12-27. doi: 10.1159/000445350. Epub 2016 May 12.
4
Precision Nutrition 4.0: A Big Data and Ethics Foresight Analysis--Convergence of Agrigenomics, Nutrigenomics, Nutriproteomics, and Nutrimetabolomics.精准营养4.0：大数据与伦理前瞻性分析——农业基因组学、营养基因组学、营养蛋白质组学和营养代谢组学的融合
OMICS. 2016 Feb;20(2):69-75. doi: 10.1089/omi.2015.0193. Epub 2016 Jan 19.
5
Nutrigenetics and nutrigenomics: ready for clinical use or still a way to go?营养遗传学与营养基因组学：已准备好用于临床应用，还是仍有很长的路要走？
Per Med. 2020 May 1;17(3):171-173. doi: 10.2217/pme-2020-0007. Epub 2020 Apr 24.
6
THE PRESENT AND FUTURE OF PERSONALIZED NUTRITION.个性化营养的现状与未来。
Rev Invest Clin. 2021;73(5):321-325. doi: 10.24875/RIC.21000346.
7
Future challenges and present ethical considerations in the use of personalized nutrition based on genetic advice.基于基因建议的个性化营养应用中的未来挑战与当前伦理考量
J Acad Nutr Diet. 2013 Nov;113(11):1447-1454. doi: 10.1016/j.jand.2013.05.028. Epub 2013 Aug 2.
8
Precision Obesity Treatments Including Pharmacogenetic and Nutrigenetic Approaches.精准肥胖治疗包括遗传药理学和营养遗传学方法。
Trends Pharmacol Sci. 2016 Jul;37(7):575-593. doi: 10.1016/j.tips.2016.04.008. Epub 2016 May 25.
9
Personalized nutrition for dementia prevention.针对痴呆症的个性化营养。
Alzheimers Dement. 2022 Jul;18(7):1424-1437. doi: 10.1002/alz.12486. Epub 2021 Nov 10.
10
Precision (Personalized) Nutrition: Understanding Metabolic Heterogeneity.精准（个性化）营养：理解代谢异质性。
Annu Rev Food Sci Technol. 2020 Mar 25;11:71-92. doi: 10.1146/annurev-food-032519-051736. Epub 2020 Jan 13.
引用本文的文献
1
Pharmacotherapy for obesity: are we ready to select, tailor and combine pharmacotherapy to achieve more ambitious goals?肥胖症的药物治疗：我们是否准备好选择、定制和联合药物治疗以实现更宏伟的目标？
Front Endocrinol (Lausanne). 2025 Jun 18;16:1569468. doi: 10.3389/fendo.2025.1569468. eCollection 2025.
2
Unraveling the Genetic Architecture of Obesity: A Path to Personalized Medicine.解析肥胖的遗传结构：通往个性化医疗之路。
Diagnostics (Basel). 2025 Jun 11;15(12):1482. doi: 10.3390/diagnostics15121482.
3
Body Composition and Its Outcomes and Management in Multiple Sclerosis: Narrative Review.多发性硬化症的身体成分及其后果与管理：叙述性综述
Nutrients. 2025 Mar 14;17(6):1021. doi: 10.3390/nu17061021.
4
The Spanish GIRO Guideline: A Paradigm Shift in the Management of Obesity in Adults.西班牙GIRO指南：成人肥胖管理的范式转变。
Obes Facts. 2025 Mar 29:1-13. doi: 10.1159/000544880.
5
Adult obesity treatment and prevention: A trans-agency commentary on the research landscape, gaps, and future opportunities.成人肥胖症的治疗与预防：跨部门对研究现状、差距及未来机遇的评论
Obes Rev. 2024 Sep;25(9):e13769. doi: 10.1111/obr.13769. Epub 2024 Jun 3.
6
The melanocortin-4 receptor pathway and the emergence of precision medicine in obesity management.黑素皮质素 4 受体途径与肥胖管理中精准医学的出现。
Diabetes Obes Metab. 2024 Apr;26 Suppl 2(Suppl 2):46-63. doi: 10.1111/dom.15555. Epub 2024 Mar 19.
7
Weight-centric prevention of cancer.以体重为中心的癌症预防。
Obes Pillars. 2024 Mar 5;10:100106. doi: 10.1016/j.obpill.2024.100106. eCollection 2024 Jun.
8
Exploring Genetic Testing for Rare Disorders of Obesity: Experience and Perspectives of Pediatric Weight Management Providers.探索肥胖罕见疾病的基因检测：儿科体重管理提供者的经验和观点。
Child Obes. 2024 Oct;20(7):451-458. doi: 10.1089/chi.2023.0125. Epub 2024 Jan 8.
9
Clinical review: Guide to pharmacological management in pediatric obesity medicine.临床综述：儿童肥胖医学药理学管理指南
Obes Pillars. 2023 Apr 27;6:100066. doi: 10.1016/j.obpill.2023.100066. eCollection 2023 Jun.
10
Efficacy of Antiobesity Medications in Patients With Celiac Disease on a Gluten-free Diet: A Retrospective Matched Cohort Study.基于无麸质饮食的乳糜泻患者使用抗肥胖药物的疗效：一项回顾性匹配队列研究。
J Clin Gastroenterol. 2024 Aug 1;58(7):650-655. doi: 10.1097/MCG.0000000000001931.
本文引用的文献
1
A Review on Role of Microbiome in Obesity and Antiobesity Properties of Probiotic Supplements.肠道菌群在肥胖中的作用及益生菌补充剂的抗肥胖特性研究进展
Biomed Res Int. 2019 May 9;2019:3291367. doi: 10.1155/2019/3291367. eCollection 2019.
2
Are we close to defining a metabolomic signature of human obesity? A systematic review of metabolomics studies.我们是否即将定义人类肥胖的代谢组学特征？代谢组学研究的系统评价。
Metabolomics. 2019 Jun 13;15(6):93. doi: 10.1007/s11306-019-1553-y.
3
Genetics and epigenetics in obesity.肥胖的遗传学和表观遗传学。
Metabolism. 2019 Mar;92:37-50. doi: 10.1016/j.metabol.2018.10.007. Epub 2018 Nov 3.
4
Profound Perturbation of the Metabolome in Obesity Is Associated with Health Risk.肥胖症患者的代谢组发生深刻变化，与健康风险相关。
Cell Metab. 2019 Feb 5;29(2):488-500.e2. doi: 10.1016/j.cmet.2018.09.022. Epub 2018 Oct 11.
5
Polymorphisms of peroxisome proliferator-activated receptor γ (PPARγ) and cluster of differentiation 36 (CD36) associated with valproate-induced obesity in epileptic patients.与癫痫患者丙戊酸诱导肥胖相关的过氧化物酶体增殖物激活受体 γ（PPARγ）和分化群 36（CD36）多态性。
Psychopharmacology (Berl). 2018 Sep;235(9):2665-2673. doi: 10.1007/s00213-018-4960-2. Epub 2018 Jul 8.
6
Exercise training alters the genomic response to acute exercise in human adipose tissue.运动训练改变了人类脂肪组织对急性运动的基因组反应。
Epigenomics. 2018 Aug;10(8):1033-1050. doi: 10.2217/epi-2018-0039. Epub 2018 Apr 19.
7
Effect of Low-Fat vs Low-Carbohydrate Diet on 12-Month Weight Loss in Overweight Adults and the Association With Genotype Pattern or Insulin Secretion: The DIETFITS Randomized Clinical Trial.低脂饮食与低碳水化合物饮食对超重成年人12个月体重减轻的影响以及与基因型模式或胰岛素分泌的关联：DIETFITS随机临床试验
JAMA. 2018 Feb 20;319(7):667-679. doi: 10.1001/jama.2018.0245.
8
Genetics of Obesity in Consanguineous Populations: Toward Precision Medicine and the Discovery of Novel Obesity Genes.同血缘人群肥胖的遗传学研究：迈向精准医学和新型肥胖基因的发现。
Obesity (Silver Spring). 2018 Mar;26(3):474-484. doi: 10.1002/oby.22064.
9
Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency.MC4R 缺乏症中黑皮质素-4 受体（MC4R）激动剂（Setmelanotide）的评估。
Mol Metab. 2017 Oct;6(10):1321-1329. doi: 10.1016/j.molmet.2017.06.015. Epub 2017 Jul 8.
10
Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial.利拉鲁肽对肥胖患者体重、饱腹感和胃功能的影响：一项随机、安慰剂对照的初步试验。
Lancet Gastroenterol Hepatol. 2017 Dec;2(12):890-899. doi: 10.1016/S2468-1253(17)30285-6. Epub 2017 Sep 27.
Zotero 插件